Back to mobile site
Get it on Google Play

Arvinas to present ARV-102 Parkinson's trial data at MDS congress

October 1, 2026 4:01 PM EDT Send to a Friend
Arvinas, Inc. (Nasdaq: ARVN) said it will present biomarker data from a Phase 1 clinical trial of its investigational drug ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login